Endothelial progenitor cells in cardiovascular disease and chronic inflammation: From biomarker to therapeutic agent

Biomarkers in Medicine

Volumn 5, Issue 6, 2011, Pages 731-744

  Grisar, Johannes C ^a   Haddad, Francois ^a   Gomari, Fatemeh A ^a   Wu, Joseph C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

biomarker; cardiovascular disease; endothelial progenitor cell; inflammation; vasculogenesis

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CD45 ANTIGEN; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; GLITAZONE DERIVATIVE; GROWTH FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ANGIOGENESIS; ATHEROSCLEROSIS; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CARDIOVASCULAR DISEASE; CELL ACTIVITY; CELL DIFFERENTIATION; CELL LINEAGE; CELL SPECIFICITY; CHRONIC INFLAMMATION; COMORBIDITY; CROSS-SECTIONAL STUDY; CYTOLOGY; DIET THERAPY; DISEASE MARKER; ENDOTHELIAL PROGENITOR CELL; EXERCISE; FLOW CYTOMETRY; HEALTH STATUS; HEART FAILURE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNE SYSTEM; ISCHEMIC HEART DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; REVIEW; RHEUMATOID ARTHRITIS; STEM CELL MOBILIZATION; THERAPY EFFECT;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CELL DIFFERENTIATION; DIABETES MELLITUS; ENDOTHELIUM, VASCULAR; HUMANS; INFLAMMATION; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 82755166899     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.11.92     Document Type: Review

References (144)

1. Folkman J. Angiogenesis. Annu. Rev. Med. 57, 1-18 (2006). (Pubitemid 43261975)
2. Rafii S, Oz MC, Seldomridge JA et al. Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices. Ann. Thorac. Surg. 60(6), 1627-1632 (1995). (Pubitemid 26078252)
3. Sbarbati R, de Boer M, Marzilli M, Scarlattini M, Rossi G, van Mourik JA. Immunologic detection of endothelial cells in human whole blood. Blood 77(4), 764-769 (1991).
4. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis Science 275(5302), 964-967 (1997). (Pubitemid 27087709)
5. Distler JH, Allanore Y, Avouac J et al. EULAR scleroderma trials and research group statement and recommendations on endothelial precursor cells. Ann. Rheum. Dis. 68(2), 163-168 (2009).
6. George J, Shmilovich H, Deutsch V, Miller H, Keren G, Roth A. Comparative analysis of methods for assessment of circulating endothelial progenitor cells. Tissue Eng. 12(2), 331-335 (2006).
7. Khan SS, Solomon MA, McCoy JP Jr. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry B Clin. Cytom. 64(1), 1-8 (2005). (Pubitemid 40960406)
8. Ingram DA, Caplice NM, Yoder MC. Unresolved questions, changing definitions, and novel paradigms for defining endothelial progenitor cells. Blood 106(5), 1525-1531 (2005). (Pubitemid 41208561)
9. Schmidt-Lucke C, Fichtlscherer S, Aicher A et al. Quantification of circulating endothelial progenitor cells using the modified ISHAGE protocol. PLoS One 5(11), e13790 (2010).
10. Van Craenenbroeck EM, Conraads VM, Van Bockstaele DR et al. Quantification of circulating endothelial progenitor cells: a methodological comparison of six flow cytometric approaches. J. Immunol. Methods 332(1-2), 31-40 (2008).
11. Kalka C, Masuda H, Takahashi T et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc. Natl Acad. Sci. USA 97(7), 3422-3427 (2000). (Pubitemid 30183318)
12. Vasa M, Fichtlscherer S, Adler K et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103(24), 2885-2890 (2001). (Pubitemid 32578123)
13. Hill JM, Zalos G, Halcox JP et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N. Engl. J. Med. 348(7), 593-600 (2003). (Pubitemid 36204953)
14. Ingram DA, Mead LE, Tanaka H et al. Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104(9), 2752-2760 (2004). (Pubitemid 39434958)
15. Rehman J, Li J, Orschell CM, March KL. Peripheral blood 'endothelial progenitor cells' are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 107(8), 1164-1169 (2003). (Pubitemid 36297209)
16. Gulati R, Jevremovic D, Peterson TE et al. Diverse origin and function of cells with endothelial phenotype obtained from adult human blood. Circ. Res. 93(11), 1023-1025 (2003). (Pubitemid 37485031)
17. Yoder MC. Defining human endothelial progenitor cells. J. Thromb. Haemost. 7(Suppl. 1), 49-52 (2009).
18. Yoder MC, Mead LE, Prater D et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109(5), 1801-1809 (2007). (Pubitemid 46348173)
19. Urbich C, Dimmeler S. Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 95(4), 343-353 (2004). (Pubitemid 39100452)
20. Gehling UM, Ergun S, Schumacher U et al. In vitro differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95(10), 3106-3112 (2000). (Pubitemid 30321161)
21. Case J, Mead LE, Bessler WK et al. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp. Hematol. 35(7), 1109-1118 (2007). (Pubitemid 46921310)
22. Richardson MR, Yoder MC. Endothelial progenitor cells: quo vadis? J. Mol. Cell. Cardiol. 50(2), 266-272 (2011).
23. Estes ML, Mund JA, Ingram DA, Case J. Identification of endothelial cells and progenitor cell subsets in human peripheral blood. Curr. Protoc. Cytom. Chapter 9, Unit 9, 33, 1-11 (2010).
24. Loomans CJ, de Koning EJ, Staal FJ et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of Type 1 diabetes. Diabetes 53(1), 195-199 (2004). (Pubitemid 38044715)
25. Tepper OM, Galiano RD, Capla JM et al. Human endothelial progenitor cells from Type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures. Circulation 106(22), 2781-2786 (2002). (Pubitemid 35396976)
26. Pirro M, Schillaci G, Menecali C et al. Reduced number of circulating endothelial progenitors and HOXA9 expression in CD34+ cells of hypertensive patients. J. Hypertens. 25(10), 2093-2099 (2007). (Pubitemid 47476306)
27. Umemura T, Soga J, Hidaka T et al. Aging and hypertension are independent risk factors for reduced number of circulating endothelial progenitor cells. Am. J. Hypertens. 21(11), 1203-1209 (2008).
28. Choi JH, Kim KL, Huh W et al. Decreased number and impaired angiogenic function of endothelial progenitor cells in patients with chronic renal failure. Arterioscler. Thromb. Vasc. Biol. 24(7), 1246-1252 (2004). (Pubitemid 38880016)
29. de Groot K, Bahlmann FH, Sowa J et al. Uremia causes endothelial progenitor cell deficiency. Kidney Int. 66(2), 641-646 (2004). (Pubitemid 38982006)
30. Lorenzen J, David S, Bahlmann FH et al. Endothelial progenitor cells and cardiovascular events in patients with chronic kidney disease: a prospective follow-up study. PLoS One 5(7), e11477 (2010).
31. Werner N, Kosiol S, Schiegl T et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N. Engl. J. Med. 353(10), 999-1007 (2005). (Pubitemid 41262334)
32. Ghani U, Shuaib A, Salam A et al. Endothelial progenitor cells during cerebrovascular disease. Stroke 36(1), 151-153 (2005). (Pubitemid 40054193)
33. Shintani S, Murohara T, Ikeda H et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103(23), 2776-2779 (2001). (Pubitemid 32550062)
34. George J, Goldstein E, Abashidze S et al. Circulating endothelial progenitor cells in patients with unstable angina: association with systemic inflammation. Eur. Heart J. 25(12), 1003-1008 (2004). (Pubitemid 38869417)
35. Guven H, Shepherd RM, Bach RG, Capoccia BJ, Link DC. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J. Am. Coll. Cardiol. 48(8), 1579-1587 (2006). (Pubitemid 44528190)
36. Valgimigli M, Rigolin GM, Fucili A et al. CD34+ and endothelial progenitor cells in patients with various degrees of congestive heart failure. Circulation 110(10), 1209-1212 (2004). (Pubitemid 39202334)
37. Diller GP, van Eijl S, Okonko DO et al. Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension. Circulation 117(23), 3020-3030 (2008).
38. Fadini GP, Schiavon M, Rea F, Avogaro A, Agostini C. Depletion of endothelial progenitor cells may link pulmonary fibrosis and pulmonary hypertension. Am. J. Respir. Crit. Care Med. 176(7), 724-725, author reply 725 (2007). (Pubitemid 47503082)
39. Junhui Z, Xingxiang W, Guosheng F, Yunpeng S, Furong Z, Junzhu C. Reduced number and activity of circulating endothelial progenitor cells in patients with idiopathic pulmonary arterial hypertension. Respir. Med. 102(7), 1073-1079 (2008).
40. Toshner M, Voswinckel R, Southwood M et al. Evidence of dysfunction of endothelial progenitors in pulmonary arterial hypertension. Am. J. Respir. Crit. Care Med. 180(8), 780-787 (2009).
41. Asosingh K, Aldred MA, Vasanji A et al. Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension. Am. J. Pathol. 172(3), 615-627 (2008). (Pubitemid 351354535)
42. Thomas HE, Parry G, Dark JH, Arthur HM, Keavney BD. Circulating endothelial progenitor cell numbers are not associated with donor organ age or allograft vasculopathy in cardiac transplant recipients. Atherosclerosis 202(2), 612-616 (2009).
43. Caplice NM, Bunch TJ, Stalboerger PG et al. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc. Natl Acad. Sci. USA 100(8), 4754-4759 (2003). (Pubitemid 36457802)
44. Osto E, Castellani C, Fadini GP et al. Impaired endothelial progenitor cell recruitment may contribute to heart transplant microvasculopathy. J. Heart Lung Transplant 30(1), 70-76 (2011).
45. Schmidt-Lucke C, Rossig L, Fichtlscherer S et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111(22), 2981-2987 (2005). (Pubitemid 40814192)
46. Xiao Q, Kiechl S, Patel S et al. Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis -results from a large population-based study. PLoS One 2(10), e975 (2007).
47. Hristov M, Zernecke A, Liehn EA, Weber C. Regulation of endothelial progenitor cell homing after arterial injury. Thromb. Haemost. 98(2), 274-277 (2007). (Pubitemid 47250227)
48. Hristov M, Zernecke A, Bidzhekov K et al. Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ. Res. 100(4), 590-597 (2007). (Pubitemid 46673269)
49. George J, Afek A, Abashidze A et al. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice. Arterioscler. Thromb. Vasc. Biol. 25(12), 2636-2641 (2005). (Pubitemid 43732290)
50. Sata M, Saiura A, Kunisato A et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat. Med. 8(4), 403-409 (2002). (Pubitemid 34407037)
51. Torsney E, Mandal K, Halliday A, Jahangiri M, Xu Q. Characterisation of progenitor cells in human atherosclerotic vessels. Atherosclerosis 191(2), 259-264 (2007). (Pubitemid 46400709)
52. Hagensen MK, Shim J, Thim T, Falk E, Bentzon JF. Circulating endothelial progenitor cells do not contribute to plaque endothelium in murine atherosclerosis. Circulation 121(7), 898-905 (2010).
53. Fadini GP, Avogaro A. Potential manipulation of endothelial progenitor cells in diabetes and its complications. Diabetes Obes. Metab. 12(7), 570-583 (2010).
54. Fadini GP, Miorin M, Facco M et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of Type 2 diabetes mellitus. J. Am. Coll. Cardiol. 45(9), 1449-1457 (2005). (Pubitemid 40615617)
55. Fadini GP, Sartore S, Albiero M et al. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler. Thromb. Vasc. Biol. 26(9), 2140-2146 (2006). (Pubitemid 44253800)
56. Fadini GP, Sartore S, Baesso I et al. Endothelial progenitor cells and the diabetic paradox. Diabetes Care 29(3), 714-716 (2006). (Pubitemid 44115383)
57. Makino H, Okada S, Nagumo A et al. Decreased circulating CD34+ cells are associated with progression of diabetic nephropathy. Diabet. Med. 26(2), 171-173 (2009).
58. Fadini GP, Maruyama S, Ozaki T et al. Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis. PLoS One 5(7), e11488 (2010).
59. Michowitz Y, Goldstein E, Wexler D, Sheps D, Keren G, George J. Circulating endothelial progenitor cells and clinical outcome in patients with congestive heart failure. Heart 93(9), 1046-1050 (2007). (Pubitemid 47310980)
60. Erbs S, Hollriegel R, Linke A et al. Exercise training in patients with advanced chronic heart failure (NYHA IIIb) promotes restoration of peripheral vasomotor function, induction of endogenous regeneration, and improvement of left ventricular function. Circ. Heart Fail. 3(4), 486-494 (2010).
61. Yao W, Firth AL, Sacks RS et al. Identification of putative endothelial progenitor cells (CD34+CD133+Flk-1+) in endarterectomized tissue of patients with chronic thromboembolic pulmonary hypertension. Am. J. Physiol. Lung Cell. Mol. Physiol. 296(6), L870-L878 (2009).
62. Diller GP, Thum T, Wilkins MR, Wharton J. Endothelial progenitor cells in pulmonary arterial hypertension. Trends Cardiovasc. Med. 20(1), 22-29 (2010).
63. Wolfe F, Mitchell DM, Sibley JT et al. The mortality of rheumatoid arthritis. Arthritis Rheum. 37(4), 481-494 (1994). (Pubitemid 24115934)
64. del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 44(12), 2737-2745 (2001). (Pubitemid 34016192)
65. Sarzi-Puttini P, Atzeni F, Gerli R et al. Cardiac involvement in systemic rheumatic diseases: an update. Autoimmun. Rev. 9(12), 849-852 (2010).
66. Szekanecz Z, Koch AE. Vascular involvement in rheumatic diseases: 'vascular rheumatology'. Arthritis Res. Ther. 10(5), 224 (2008).
67. Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of systemic lupus erythematosus. Am. J. Med. 60(2), 221-225 (1976).
68. Rubin LA, Urowitz MB, Gladman DD. Mortality in systemic lupus erythematosus: the bimodal pattern revisited. Q. J. Med. 55(216), 87-98 (1985). (Pubitemid 15105095)
69. Grisar J, Aletaha D, Steiner CW et al. Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation 111(2), 204-211 (2005). (Pubitemid 40139733)
70. Grisar J, Aletaha D, Steiner CW et al. Endothelial progenitor cells in active rheumatoid arthritis: effects of tumour necrosis factor and glucocorticoid therapy. Ann. Rheum. Dis. 66(10), 1284-1288 (2007). (Pubitemid 47492469)
71. Herbrig K, Haensel S, Oelschlaegel U, Pistrosch F, Foerster S, Passauer J. Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells. Ann. Rheum. Dis. 65(2), 157-163 (2006). (Pubitemid 43131987)
72. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 38(1), 44-48 (1995).
73. Ruger B, Giurea A, Wanivenhaus AH et al. Endothelial precursor cells in the synovial tissue of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum. 50(7), 2157-2166 (2004). (Pubitemid 38924393)
74. Silverman MD, Haas CS, Rad AM, Arbab AS, Koch AE. The role of vascular cell adhesion molecule-1/very late activation antigen 4 in endothelial progenitor cell recruitment to rheumatoid arthritis synovium. Arthritis Rheum. 56(6), 1817-1826 (2007). (Pubitemid 47110381)
75. Paleolog E. It's all in the blood: circulating endothelial progenitor cells link synovial vascularity with cardiovascular mortality in rheumatoid arthritis? Arthritis Res. Ther. 7(6), 270-272 (2005). (Pubitemid 41646257)
76. Moonen JR, de Leeuw K, van Seijen XJ et al. Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus. Arthritis Res. Ther. 9(4), R84 (2007).
77. Westerweel PE, Luijten RK, Hoefer IE, Koomans HA, Derksen RH, Verhaar MC. Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus. Ann. Rheum. Dis. 66(7), 865-870 (2007). (Pubitemid 46999785)
78. Denny MF, Thacker S, Mehta H et al. Interferon-a promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis. Blood 110(8), 2907-2915 (2007). (Pubitemid 350006944)
79. Lee PY, Li Y, Richards HB et al. Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus. Arthritis Rheum. 56(11), 3759-3769 (2007). (Pubitemid 350100709)
80. Ebner P, Picard F, Richter J et al. Accumulation of VEGFR-2+/CD133+ cells and decreased number and impaired functionality of CD34+/VEGFR-2+ cells in patients with SLE. Rheumatology (Oxford) 49(1), 63-72 (2010).
81. Deng XL, Li XX, Liu XY, Sun L, Liu R. Comparative study on circulating endothelial progenitor cells in systemic lupus erythematosus patients at active stage. Rheumatol. Int. 30(11), 1429-1436 (2009).
82. Grisar J, Steiner CW, Bonelli M et al. Systemic lupus erythematosus patients exhibit functional deficiencies of endothelial progenitor cells. Rheumatology (Oxford) 47(10), 1476-1483 (2008).
83. Kuwana M, Okazaki Y, Yasuoka H, Kawakami Y, Ikeda Y. Defective vasculogenesis in systemic sclerosis. Lancet 364(9434), 603-610 (2004). (Pubitemid 39094178)
84. Del Papa N, Colombo G, Fracchiolla N et al. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis. Arthritis Rheum. 50(4), 1296-1304 (2004). (Pubitemid 38480841)
85. Allanore Y, Batteux F, Avouac J, Assous N, Weill B, Kahan A. Levels of circulating endothelial progenitor cells in systemic sclerosis. Clin. Exp. Rheumatol. 25(1), 60-66 (2007). (Pubitemid 46477487)
86. Avouac J, Juin F, Wipff J et al. Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity. Ann. Rheum. Dis. 67(10), 1455-1460 (2008).
87. Nevskaya T, Bykovskaia S, Lyssuk E et al. Circulating endothelial progenitor cells in systemic sclerosis: relation to impaired angiogenesis and cardiovascular manifestations. Clin. Exp. Rheumatol. 26(3), 421-429 (2008). (Pubitemid 352003210)
88. Ferri C, Giuggioli D, Manfredi A et al. Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers. Clin. Exp. Dermatol. 35(8), 885-887 (2010).
89. Furuya Y, Okazaki Y, Kaji K, Sato S, Takehara K, Kuwana M. Mobilization of endothelial progenitor cells by intravenous cyclophosphamide in patients with systemic sclerosis. Rheumatology (Oxford) 49(12), 2375-2380 (2010).
90. Takahashi K, Oharaseki T, Yokouchi Y. Pathogenesis of Kawasaki disease. Clin. Exp. Immunol. 164(Suppl. 1), 20-22 (2011).
91. Kuroi A, Imanishi T, Suzuki H et al. Clinical characteristics of patients with kawasaki disease and levels of peripheral endothelial progenitor cells and blood monocyte subpopulations. Circ. J. 74(12), 2720-2725 (2010).
92. Xu MG, Men LN, Zhao CY et al. The number and function of circulating endothelial progenitor cells in patients with Kawasaki disease. Eur. J. Pediatr. 169(3), 289-296 (2010).
93. Xu MG, Men LN, Zu Y, Zhao CY, Meng XC, Wang T. The functions of endothelial progenitor cells were significantly improved after treatment with intravenous immunoglobulin and aspirin in children with Kawasaki disease. Pediatr. Cardiol. 32(4), 455-460 (2011).
94. Ridker PM, Cook NR. Biomarkers for prediction of cardiovascular events. N. Engl. J. Med. 356(14), 1472-1473; author reply 1474-1475 (2007).
95. Libby P, Ridker PM, Hansson GK. Inflammation in atherosclerosis: from pathophysiology to practice. J. Am. Coll. Cardiol. 54(23), 2129-2138 (2009).
96. Bartoloni E, Shoenfeld Y, Gerli R. Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: two faces of the same coin. Arthritis Care Res. (Hoboken) 63(2), 178-183 (2011).
97. Westerweel PE, Verhaar MC. Endothelial progenitor cell dysfunction in rheumatic disease. Nat. Rev. Rheumatol. 5(6), 332-340 (2009).
98. Smolen JS, Redlich K, Zwerina J, Aletaha D, Steiner G, Schett G. Pro-inflammatory cytokines in rheumatoid arthritis: pathogenetic and therapeutic aspects. Clin. Rev. Allergy Immunol. 28(3), 239-248 (2005). (Pubitemid 41208913)
99. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl. J. Med. 340, 448-454 (1999). (Pubitemid 29084777)
100. Verma S, Kuliszewski MA, Li SH et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 109(17), 2058-2067 (2004). (Pubitemid 38620212)
101. Ciulla MM, Giorgetti A, Silvestris I et al. Endothelial colony forming capacity is related to C-reactive protein levels in healthy subjects. Curr. Neurovasc. Res. 3(2), 99-106 (2006). (Pubitemid 43764786)
102. Fujii H, Li SH, Szmitko PE, Fedak PW, Verma S. C-reactive protein alters antioxidant defenses and promotes apoptosis in endothelial progenitor cells. Arterioscler. Thromb. Vasc. Biol. 26(11), 2476-2482 (2006). (Pubitemid 44607468)
103. Chen J, Huang L, Song M, Yu S, Gao P, Jing J. C-reactive protein upregulates receptor for advanced glycation end products expression and alters antioxidant defenses in rat endothelial progenitor cells. J. Cardiovasc. Pharmacol. 53(5), 359-367 (2009).
104. Goussetis E, Spiropoulos A, Tsironi M et al. Spartathlon, a 246 kilometer foot race: effects of acute inflammation induced by prolonged exercise on circulating progenitor reparative cells. Blood Cells Mol. Dis. 42(3), 294-299 (2009).
105. Adams V, Linke A, Breuckmann F et al. Circulating progenitor cells decrease immediately after marathon race in advanced-age marathon runners. Eur. J. Cardiovasc. Prev. Rehabil. 15(5), 602-607 (2008).
106. Ahrens I, Domeij H, Eisenhardt SU et al. Opposing effects of monomeric and pentameric C-reactive protein on endothelial progenitor cells. Basic Res. Cardiol. 106(5), 879-895 (2011).
107. Eklund CM. Proinflammatory cytokines in CRP baseline regulation. Adv. Clin. Chem. 48, 111-136 (2009).
108. Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res. Ther. 8(Suppl. 2), S3 (2006).
109. Patel AM, Moreland LW. Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy. Drug Des. Devel. Ther. 4, 263-278 (2010).
110. Fan Y, Ye J, Shen F et al. Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro. J. Cereb. Blood Flow Metab. 28(1), 90-98 (2008).
111. Bonsignore MR, Morici G, Riccioni R et al. Hemopoietic and angiogenetic progenitors in healthy athletes: different responses to endurance and maximal exercise. J. Appl. Physiol. 109(1), 60-67 (2010).
112. Ablin JN, Boguslavski V, Aloush V et al. Effect of anti-TNFa treatment on circulating endothelial progenitor cells (EPCs) in rheumatoid arthritis. Life Sci. 79(25), 2364-2369 (2006). (Pubitemid 44772932)
113. Sibal L, Aldibbiat A, Agarwal SC et al. Circulating endothelial progenitor cells, endothelial function, carotid intima-media thickness and circulating markers of endothelial dysfunction in people with Type 1 diabetes without macrovascular disease or microalbuminuria. Diabetologia 52(8), 1464-1473 (2009).
114. Chen TG, Zhong ZY, Sun GF, Zhou YX, Zhao Y. Effects of tumour necrosis factor-a on activity and nitric oxide synthase of endothelial progenitor cells from peripheral blood. Cell Prolif. 44(4), 352-359 (2011).
115. Henrich D, Seebach C, Wilhelm K, Marzi I. High dosage of simvastatin reduces TNF-a-induced apoptosis of endothelial progenitor cells but fails to prevent apoptosis induced by IL-1b in vitro. J. Surg. Res. 142(1), 13-19 (2007). (Pubitemid 47267991)
116. Balestrieri ML, Schiano C, Felice F et al. Effect of low doses of red wine and pure resveratrol on circulating endothelial progenitor cells. J. Biochem. 143(2), 179-186 (2008). (Pubitemid 351249832)
117. Ribatti D, Nico B, Crivellato E, Vacca A. Endothelial progenitor cells in health and disease. Histol. Histopathol. 20(4), 1351-1358 (2005). (Pubitemid 41489178)
118. Rehman J, Li J, Parvathaneni L et al. Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells. J. Am. Coll. Cardiol. 43(12), 2314-2318 (2004). (Pubitemid 38757604)
119. Steiner S, Niessner A, Ziegler S et al. Endurance training increases the number of endothelial progenitor cells in patients with cardiovascular risk and coronary artery disease. Atherosclerosis 181(2), 305-310 (2005). (Pubitemid 41019611)
120. Laufs U, Urhausen A, Werner N et al. Running exercise of different duration and intensity: effect on endothelial progenitor cells in healthy subjects. Eur. J. Cardiovasc. Prev. Rehabil. 12(4), 407-414 (2005). (Pubitemid 41192175)
121. Schlager O, Giurgea A, Schuhfried O et al. Exercise training increases endothelial progenitor cells and decreases asymmetric dimethylarginine in peripheral arterial disease: a randomized controlled trial. Atherosclerosis 217(1), 240-248 (2011).
122. Kim W, Jeong MH, Cho SH et al. Effect of green tea consumption on endothelial function and circulating endothelial progenitor cells in chronic smokers. Circ. J. 70(8), 1052-1057 (2006). (Pubitemid 44161745)
123. Marin C, Ramirez R, Delgado-Lista J et al. Mediterranean diet reduces endothelial damage and improves the regenerative capacity of endothelium. Am. J. Clin. Nutr. 93(2), 267-274 (2010).
124. Westerweel PE, Visseren FL, Hajer GR et al. Endothelial progenitor cell levels in obese men with the metabolic syndrome and the effect of simvastatin monotherapy vs. simvastatin/ezetimibe combination therapy. Eur. Heart J. 29(22), 2808-2817 (2008).
125. Ludwig A, Jochmann N, Kertesz A et al. Smoking decreases the level of circulating CD34+ progenitor cells in young healthy women -a pilot study. BMC Womens Health 10, 20 (2010).
126. Dimmeler S, Aicher A, Vasa M et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI3-kinase/Akt pathway. J. Clin. Invest. 108(3), 391-397 (2001). (Pubitemid 32730785)
127. Bahlmann FH, DeGroot K, Duckert T et al. Endothelial progenitor cell proliferation and differentiation is regulated by erythropoietin. Kidney Int. 64(5), 1648-1652 (2003). (Pubitemid 37323692)
128. Mueller C, Wodack K, Twelker K, Werner N, Custodis F, Nickenig G. Darbepoetin improves endothelial function and increases circulating endothelial progenitor cell number in patients with coronary artery disease. Heart 97(18), 1474-1478 (2011).
129. Pistrosch F, Herbrig K, Oelschlaegel U et al. PPARg-agonist rosiglitazone increases number and migratory activity of cultured endothelial progenitor cells. Atherosclerosis 183(1), 163-167 (2005). (Pubitemid 41416835)
130. Wang CH, Ciliberti N, Li SH et al. Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy. Circulation 109(11), 1392-1400 (2004). (Pubitemid 38387826)
131. Cianfrocca C, Loricchio ML, Pelliccia F et al. C-reactive protein and left atrial appendage velocity are independent determinants of the risk of thrombogenesis in patients with atrial fibrillation. Int. J. Cardiol. 142(1), 22-28 (2010).
132. Bahlmann FH, de Groot K, Mueller O, Hertel B, Haller H, Fliser D. Stimulation of endothelial progenitor cells: a new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension 45(4), 526-529 (2005). (Pubitemid 40411254)
133. Min TQ, Zhu CJ, Xiang WX, Hui ZJ, Peng SY. Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease. Cardiovasc. Drugs Ther. 18, 203-209 (2004). (Pubitemid 38918955)
134. Stamm C, Kleine HD, Westphal B et al. CABG and bone marrow stem cell transplantation after myocardial infarction. Thorac. Cardiovasc. Surg. 52(3), 152-158 (2004). (Pubitemid 38832922)
135. Stamm C, Westphal B, Kleine HD et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361(9351), 45-46 (2003). (Pubitemid 36050962)
136. Bartunek J, Vanderheyden M, Vandekerckhove B et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 112(Suppl. 9), I178-I183 (2005). (Pubitemid 41266671)
137. Vanderheyden M, Vercauteren S, Mansour S et al. Time-dependent effects on coronary remodeling and epicardial conductance after intracoronary injection of enriched hematopoietic bone marrow stem cells in patients with previous myocardial infarction. Cell Transplant. 16(9), 919-925 (2007). (Pubitemid 351448609)
138. Losordo DW, Henry TD, Davidson C et al. Intramyocardial, autologous CD34+ cell therapy for refractory angina. Circ. Res. 109(4), 428-436 (2011).
139. Vrtovec B, Poglajen G, Sever M et al. Effects of intracoronary stem cell transplantation in patients with dilated cardiomyopathy. J. Card. Fail. 17(4), 272-281 (2010).
140. Jujo K, Hamada H, Iwakura A et al. CXCR4 blockade augments bone marrow progenitor cell recruitment to the neovasculature and reduces mortality after myocardial infarction. Proc. Natl Acad. Sci. USA 107(24), 11008-11013 (2010).
141. Pelliccia F, Cianfrocca C, Rosano G, Mercuro G, Speciale G, Pasceri V. Role of endothelial progenitor cells in restenosis and progression of coronary atherosclerosis after percutaneous coronary intervention: a prospective study. JACC Cardiovasc. Interv. 3(1), 78-86 (2010).
142. den Dekker WK, Houtgraaf JH, Onuma Y et al. Final results of the HEALING IIB trial to evaluate a bioengineered CD34 antibody coated stent (GenousStent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients. Atherosclerosis doi:10.1016/j. atherosclerosis.2011.06.032 (2011) (Epub ahead of print).
143. Sobrino T, Hurtado O, Moro MA et al. The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome. Stroke 38(10), 2759-2764 (2007). (Pubitemid 47494015)
144. Simper D, Wang S, Deb A et al. Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis. Circulation 108(2), 143-149 (2003). (Pubitemid 36871294)